IMC Chicago’s Editas Medicine EDIT Stock Holding History

IMC Chicago’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-34,094	Closed	-$303K	–	1298
2022 Q4	$302K	Sell	34,094 -45,032	-57%	-$494K	﹤0.01%	1204
2022 Q3	$969K	Sell	79,126 -4,480	-5%	-$69.8K	﹤0.01%	942
2022 Q2	$989K	Buy	83,606 +8,706	+12%	+$117K	﹤0.01%	846
2022 Q1	$1.43M	Buy	74,900 +25,910	+53%	+$482K	﹤0.01%	832
2021 Q4	$1.3M	Buy	48,990 +17,228	+54%	+$593K	﹤0.01%	915
2021 Q3	$1.3M	Buy	+31,762	New	+$1.74M	﹤0.01%	937

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IMC Chicago's EDIT Position: Q1 2023 in Review

IMC Chicago sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 34,094 shares — an estimated $303K sold.

IMC Chicago first reported a position in EDIT in Q3 2021 and held it in 6 quarters. The position peaked at $1.43M in Q1 2022. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

IMC Chicago reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
IMC Chicago sold 34,094 Editas Medicine shares in Q1 2023, an estimated $303K.
IMC Chicago first reported a position in Editas Medicine in Q3 2021 and held it in 6 quarters.
IMC Chicago's Editas Medicine position peaked at $1.43M in Q1 2022.
234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on IMC Chicago's 13F filing for Q1 2023, filed 24 Apr 2023.